Skip to main content
. 2024 Oct 16;24:1284. doi: 10.1186/s12885-024-13038-3

Table 3.

Median survival times and survival rates relative to IPAQ categories

Outcome IPAQ Patients Events Median survival time in months (95% CI) 6-month survival rate (95% CI) 12-month survival rate (95% CI) 24-month survival time (95% CI) 36-month survival rate (95% CI)
PFS low 138 116 9.0 (6.3, 11.2) 0.60 (0.52, 0.69) 0.36 (0.29, 0.45) 0.19 (0.13, 0.27) 0.13 (0.08, 0.21)
moderate 995 838 7.6 (6.7, 8.1) 0.57 (0.54, 0.60) 0.35 (0.32, 0.38) 0.22 (0.19, 0.24) 0.14 (0.12, 0.17)
high 137 124 7.2 (5.5, 9.3) 0.54 (0.46, 0.63) 0.29 (0.23, 0.38) 0.16 (0.11, 0.24) 0.11 (0.06, 0.17)
OS low 138 84 27.1 (20.4, 35.6) 0.89 (0.84, 0.95) 0.73 (0.65, 0.81) 0.52 (0.44, 0.62) 0.39 (0.31, 0.49)
moderate 995 597 27.7 (24.6, 30.3) 0.90 (0.89, 0.92) 0.76 (0.73, 0.78) 0.54 (0.51, 0.57) 0.41 (0.38, 0.44)
high 137 74 33.5 (25.7, 40.0) 0.93 (0.88, 0.97) 0.83 (0.76, 0.90) 0.62 (0.54, 0.71) 0.46 (0.38, 0.56)

PFS Progression free survival, OS Overall survival, IPAQ International Physical Activity Questionnaire, CI Confidence interval